PT3541409T - Monómeros modificados de ftc beta e a sua utilização para inibição da sinalização de ftc beta - Google Patents

Monómeros modificados de ftc beta e a sua utilização para inibição da sinalização de ftc beta

Info

Publication number
PT3541409T
PT3541409T PT178714721T PT17871472T PT3541409T PT 3541409 T PT3541409 T PT 3541409T PT 178714721 T PT178714721 T PT 178714721T PT 17871472 T PT17871472 T PT 17871472T PT 3541409 T PT3541409 T PT 3541409T
Authority
PT
Portugal
Prior art keywords
tgf
beta
engineered
monomers
inhibiting
Prior art date
Application number
PT178714721T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Nat Res Council Canada
Univ Pittsburgh Commonwealth Sys Higher Education
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Res Council Canada, Univ Pittsburgh Commonwealth Sys Higher Education filed Critical Nat Res Council Canada
Publication of PT3541409T publication Critical patent/PT3541409T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT178714721T 2016-11-18 2017-11-17 Monómeros modificados de ftc beta e a sua utilização para inibição da sinalização de ftc beta PT3541409T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662423920P 2016-11-18 2016-11-18

Publications (1)

Publication Number Publication Date
PT3541409T true PT3541409T (pt) 2025-02-13

Family

ID=62146703

Family Applications (1)

Application Number Title Priority Date Filing Date
PT178714721T PT3541409T (pt) 2016-11-18 2017-11-17 Monómeros modificados de ftc beta e a sua utilização para inibição da sinalização de ftc beta

Country Status (6)

Country Link
US (2) US11091523B2 (enExample)
EP (1) EP3541409B1 (enExample)
JP (3) JP7079779B2 (enExample)
ES (1) ES3011833T3 (enExample)
PT (1) PT3541409T (enExample)
WO (1) WO2018094173A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11091523B2 (en) * 2016-11-18 2021-08-17 University of Pittsburgh—of the Commonwealth System of Higher Education Engineered TGF-β monomers and their use for inhibiting TGF-β signaling
WO2021101796A1 (en) * 2019-11-18 2021-05-27 The Brigham And Women's Hospital, Inc. Codon optimized new generation regulatable fusogenic oncolytic herpes simplex virus type 1 virus and methods of use
CA3162431A1 (en) * 2020-01-21 2021-07-29 Augustinus Bader Cosmetic formulation for topical administration comprising novel peptides that improve appearance and regeneration of skin
JP2023539195A (ja) * 2020-08-27 2023-09-13 ユニバーシティ オブ ピッツバーグ － オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション 組換えトランスフォーミング増殖因子（ｔｇｆ）－ベータ単量体をコードする腫瘍溶解性ウイルスおよびその使用
EP4269429A4 (en) * 2020-12-23 2025-07-30 Korea Inst Sci & Tech NEW PEPTIDE CAPABLE OF INHIBITING TGF-BETA SIGNALING AND ITS UTILIZATION
WO2023064747A1 (en) * 2021-10-11 2023-04-20 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Engineered tgf-beta monomers and methods of use
JP2024096518A (ja) * 2023-01-03 2024-07-16 エフビーデー バイオロジクス リミテッド 操作されたｔｇｆｂｒｉｉバリアント及びその使用方法
WO2024163457A2 (en) * 2023-01-30 2024-08-08 Seattle Children's Hospital D/B/A Seattle Children's Research Institute Inducible cytokine transgenes for potentiated immune cell function
EP4490201A4 (en) 2023-05-31 2026-03-11 Fbd Biologics Ltd CD47/PD-L1 Targeted Protein Complex and Its Methods of Use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766897A (en) * 1990-06-21 1998-06-16 Incyte Pharmaceuticals, Inc. Cysteine-pegylated proteins
US5595756A (en) * 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
WO2005024035A1 (en) * 2003-09-05 2005-03-17 National Research Council Of Canada Coiled-coil fusion proteins comprising cell receptor domains
WO2011094749A2 (en) * 2010-02-01 2011-08-04 Board Of Regents, The University Of Texas System Small molecule inhibitors that block assembly of the tgf-beta signaling complex
CU24181B1 (es) * 2012-11-09 2016-04-25 Ct De Inmunología Molecular POLIPÉPTIDOS DERIVADOS DEL TGFß
US11091523B2 (en) 2016-11-18 2021-08-17 University of Pittsburgh—of the Commonwealth System of Higher Education Engineered TGF-β monomers and their use for inhibiting TGF-β signaling

Also Published As

Publication number Publication date
US20210332096A1 (en) 2021-10-28
JP2020500511A (ja) 2020-01-16
JP7079779B2 (ja) 2022-06-02
JP2023164748A (ja) 2023-11-10
EP3541409A4 (en) 2020-06-17
JP7623273B2 (ja) 2025-01-28
US20190359667A1 (en) 2019-11-28
US11091523B2 (en) 2021-08-17
EP3541409B1 (en) 2025-01-22
US12428460B2 (en) 2025-09-30
WO2018094173A1 (en) 2018-05-24
ES3011833T3 (en) 2025-04-08
EP3541409A1 (en) 2019-09-25
JP2022033239A (ja) 2022-02-28
CA3041727A1 (en) 2018-05-24

Similar Documents

Publication Publication Date Title
PT3541409T (pt) Monómeros modificados de ftc beta e a sua utilização para inibição da sinalização de ftc beta
IL259867B (en) Block-copolymers that form a polyelectrolyte layer and preparations and their uses
TWI563007B (en) Block copolymer
IL254187A0 (en) beta-tgf inhibitors
IL251872A0 (en) New polymers and dna copolymer coatings
SG11201700278UA (en) Poly(oxazoline-co-ethyleneimine)-epichlorohydrin copolymers and uses thereof
IL251051B (en) mk2 inhibitors and their uses
SG11201605714VA (en) Block copolymer and adhesive composition
SG11201605762QA (en) Block copolymer composition and adhesive composition
IL263949A (en) Complement inhibitors and their uses
GB201503393D0 (en) Polymers and uses thereof
PL3043111T3 (pl) Urządzenie sygnalizacyjne
GB201514506D0 (en) Multi-block copolymers
SG11201607082PA (en) New tetracyano-anthraquino-dimethane polymers and use thereof
IL259491A (en) Improved signaling device
PL3221878T3 (pl) Urządzenie przełączające oraz układ urządzeń przełączających
GB201515602D0 (en) Polymers and microspheres
SG11201708340QA (en) Methods and systems for olefin polymerization
IL262400A (en) Erbb inhibitors and uses thereof
GB201516067D0 (en) Defined monomer sequence polymers
SG11201709288VA (en) Copolymer
SG11201610225XA (en) Resin composition containing block copolymer
PL3491035T3 (pl) Nowe kopolimery blokowe poliakrylan-polisilan
GB201706657D0 (en) Polymers
GB201516839D0 (en) Improved tourniquet release device and tourniquet